← Back to Screener
Heartbeam, Inc. Common Stock (BEAT)
Price$0.92
Favorite Metrics
Price vs S&P 500 (26W)-52.99%
Price vs S&P 500 (4W)-29.49%
Market Capitalization$37.80M
All Metrics
Book Value / Share (Quarterly)$0.06
P/TBV (Annual)15.20x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.36
Price vs S&P 500 (YTD)-65.81%
EPS (TTM)$-0.63
10-Day Avg Trading Volume2.13M
EPS Excl Extra (TTM)$-0.63
EPS (Annual)$-0.62
ROI (Annual)-807.34%
Cash / Share (Quarterly)$0.11
ROA (Last FY)-359.66%
EBITD / Share (TTM)$-0.63
ROE (5Y Avg)-530.98%
Cash Flow / Share (Annual)$-0.36
P/B Ratio14.52x
P/B Ratio (Quarterly)31.76x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-1.04x
ROA (TTM)-353.09%
EPS Incl Extra (Annual)$-0.62
Current Ratio (Annual)1.45x
Quick Ratio (Quarterly)1.35x
3-Month Avg Trading Volume8.35M
52-Week Price Return-44.58%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.71
52-Week High$4.00
EPS Excl Extra (Annual)$-0.62
26-Week Price Return-44.24%
Quick Ratio (Annual)1.35x
13-Week Price Return-59.83%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.45x
Enterprise Value$33.421
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.11
3-Month Return Std Dev94.91%
Net Income / Employee (TTM)$-1
ROE (Last FY)-807.34%
Net Interest Coverage (Annual)-1.06x
EPS Basic Excl Extra (Annual)$-0.62
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.63
ROI (TTM)-571.06%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.30
Price vs S&P 500 (52W)-79.67%
Year-to-Date Return-61.67%
5-Day Price Return-23.33%
EPS Normalized (Annual)$-0.62
ROA (5Y Avg)-278.24%
Month-to-Date Return-24.59%
Cash Flow / Share (TTM)$-0.24
EBITD / Share (Annual)$-0.63
ROI (5Y Avg)-530.98%
EPS Basic Excl Extra (TTM)$-0.63
P/TBV (Quarterly)1.94x
P/B Ratio (Annual)31.76x
Book Value / Share (Annual)$0.06
Price vs S&P 500 (13W)-62.69%
Beta-0.62x
Revenue / Share (TTM)$0.00
ROE (TTM)-571.06%
52-Week Low$0.54
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.10
4.09
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BEATHeartbeam, Inc. Common Stock | — | — | — | — | $0.92 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
HeartBeam develops ambulatory ECG solutions using proprietary Vector Electrocardiography (VECG) technology to enable cardiac disease detection and monitoring outside traditional healthcare settings. The company's validated platform provides higher-resolution remote monitoring capabilities for telehealth applications. HeartBeam is pursuing FDA clearance for its initial telehealth products.